Utah Sues Over Off-Label Seroquel, Risperdal

Law360, New York (May 6, 2010, 7:02 PM EDT) -- AstraZeneca Pharmaceuticals Inc. and Johnson & Johnson are facing a lawsuit from the state of Utah, which is seeking to recoup payments that the state's Medicaid program handed out for off-label uses of the antipsychotics Seroquel and Risperdal and their side effects.

In a complaint filed Monday in the Third Judicial Court of Salt Lake County, Utah Attorney General Mark R. Shurtleff alleges AstraZeneca and J&J units Janssen Ortho LLC and Ortho-McNeil-Janssen Pharmaceuticals Inc. misled state authorities, physicians and consumers by marketing the two drugs for...
To view the full article, register now.